(Q34973446)

5 August 2017

1 reference

title

High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment (English)

1 reference

5 August 2017

1 reference

Laura R Benzaquen

1

1 reference

5 August 2017

Harry Yu

series ordinal

2

1 reference

5 August 2017

Nader Rifai

series ordinal

3

1 reference

5 August 2017

publication date

1 September 2002

1 reference

Critical Reviews in Clinical Laboratory Sciences

5 August 2017

published in

1 reference

5 August 2017

volume

39

1 reference

5 August 2017

issue

4-5

1 reference

5 August 2017

page(s)

459-497

1 reference

The pathogenesis of atherosclerosis (first of two parts)

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Atherosclerosis is an inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Human monocyte chemoattractant protein-1 (MCP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Compensatory enlargement of human atherosclerotic coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Low density lipoprotein oxidation and its pathobiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Lipoprotein(a) in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Vascular damage from smoking: disease mechanisms at the arterial wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Inflammation and acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Molecular bases of the acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor-induced tissue factor expression and fibrin deposition in mouse meth-A sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Primary structure of human C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Binding of C-reactive protein to C-carbohydrate and PC-substituted protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Intravenous streptokinase treatment and serum C-reactive protein in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Infections, inflammation, and the risk of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

C-reactive protein in ischemic stroke: an independent prognostic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Role of novel markers of inflammation in patients with stable coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Lipid lowering and beyond: results from the CARE study on lipoproteins and inflammation. Cholesterol and Recurrent Events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart diseas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

A major role for VCAM-1, but not ICAM-1, in early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Soluble P-selectin and the risk of future cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Fibrinogen as a major risk factor in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

A prospective study of fibrinogen and risk of myocardial infarction in the Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Statins do more than just lower cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Hormone replacement therapy and increased plasma concentration of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Rapid determination of C-reactive protein by enzyme immunoassay using two monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Plasma levels of C-reactive protein after coronary stent implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Plasma Protein Acute-Phase Response in Unstable Angina Is Not Induced by Ischemic Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

Elevated Levels of Interleukin-6 in Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360290795556

10.1080/10408360290795556

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference